Webinar Search Results : 2 Upcoming webinars found.
Lamont M. Fulton Friday, January 25, 2019
10:00 AM PST | 01:00 PM EST
Duration:60 Minutes
Price: ¤150.00
by: Lamont M. Fulton
QbD Development Process Evaluating Critical Steps
The topic of discussion focuses on practical and realistic approaches to implementation QbD, and how to apply QbD .

Lamont M. Fulton Friday, February 15, 2019
10:00 AM PST | 01:00 PM EST
Duration:60 Minutes
Price: ¤150.00
by: Lamont M. Fulton
505(B)(2) APPLICATIONs; Standards for Approval
The submission of a 505(b)(2) applications must be based on the presentation of required scientific evidence of safety and equivalency studies, These studies should show sameness of active ingredients between the proposed drug and the RLD. Thus, there must be a careful evaluation of any and all differences:

Payment Methods

Contact Us

NetZealous LLC,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.

Information

  Refund Policy
  +1-800-447-9407
  support@compliance4All.com